MarketWatch·头条· Jaimy Lee·· 2 小时前
礼来年内第三次上调销售指引，Zepbound 销售飙升带动股价上涨
Lilly raised sales guidance for third time this year as Zepbound sales soar. Its stock is rallying.
AI 导读
礼来因 Zepbound 销售飙升，年内第三次上调销售指引，股价随之上涨。该公司在美国处方减肥药市场继续保持主导地位。
来源：MarketWatch·头条 · marketwatch.com